Abstract
The control of gene expression by RNA interference (RNAi) requires that small RNAs selectively recognize sequences within the transcriptome. Complementary hybridization between the guide strand of small duplex RNAs and their targets is necessary for recognition. Proteins make a critical contribution to target recognition by protecting small RNAs from degradation by enzymes, facilitating efficient recognition, and enhancing discrimination between target sequences and closely related “off-target” sequences. Here, we focus on the Argonaute (AGO) protein family, the factor that binds directly to small RNAs, and the Trinucleotide repeat-containing protein six (TNRC6) family, scaffolding proteins that help organize gene silencing.
Original language | English (US) |
---|---|
Title of host publication | RNA Therapeutics |
Subtitle of host publication | The Evolving Landscape of RNA Therapeutics |
Publisher | Elsevier |
Pages | 17-36 |
Number of pages | 20 |
ISBN (Electronic) | 9780128215951 |
ISBN (Print) | 9780128217399 |
DOIs | |
State | Published - Jan 1 2022 |
Externally published | Yes |
Keywords
- AGO protein
- Cytoplasmic nuclear separation
- eCLIP
- Enzyme
- Immunoprecipitation
- RNA interference
- TNRC6 protein
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)